US-APR2020
- Generic Name
- US-APR2020
Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 630
- Registration Number
- NCT04913272
- Locations
- 🇺🇸
Kidney Michigan, Saginaw, Michigan, United States
🇺🇸Jadedstone Clinical Research, Silver Spring, Maryland, United States
🇺🇸South Carolina Clinical Research, Orangeburg, South Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath